Not much is known about these cytokines in relation to obesity or HDL, apart from for FGF19 which, like its related hormone FGF21 mentioned earlier, is being investigated as a pharmacological target for obesity [72]. This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.